Cargando…
Dual Size/Charge‐Switchable Nanocatalytic Medicine for Deep Tumor Therapy
Elevating intratumoral levels of highly toxic reactive oxygen species (ROS) by nanocatalytic medicine for tumor‐specific therapy without using conventional toxic chemodrugs is recently of considerable interest, which, however, still suffers from less satisfactory therapeutic efficacy due to the rela...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097343/ https://www.ncbi.nlm.nih.gov/pubmed/33977044 http://dx.doi.org/10.1002/advs.202002816 |